1. Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma. (13th March 2018) Authors: Rubinstein, Paul G.; Moore, Page C.; Rudek, Michelle A.; Henry, David H.; Ramos, Juan C.; Ratner, Lee; Reid, Erin; Sharon, Elad; Noy, Ariela Journal: AIDS Issue: Volume 32:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series. (May 2015) Authors: Kowalczyk, Mark; Rubinstein, Paul G.; Aboulafia, David M. Journal: Journal of the International Association of Providers of AIDS Care Issue: Volume 14:Number 3(2015:May/Jun.) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term survival in AIDS-related primary central nervous system lymphoma. Issue 1 (30th August 2016) Authors: Gupta, Neel K.; Nolan, Amber; Omuro, Antonio; Reid, Erin G.; Wang, Chia-Ching; Mannis, Gabriel; Jaglal, Michael; Chavez, Julio C.; Rubinstein, Paul G.; Griffin, Ann; Abrams, Donald I.; Hwang, Jimmy; Kaplan, Lawrence D.; Luce, Judith A.; Volberding, Paul; Treseler, Patrick A.; Rubenstein, James L. Journal: Neuro-oncology Issue: Volume 19:Issue 1(2017) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗